František Hubatka

František Hubatka

Auto-generated profile, based on publicly available information

František Hubatka

Veterinary Research Institute, 62100 Brno, Czech Republic

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
TŠTereza Švadláková
Tereza Švadláková
FHFrantisek Hubatka
Frantisek Hubatka
PKPavlina Turanek Knotigova
Pavlina Turanek Knotigova
PKPavel Kulich
Pavel Kulich
JMJosef Mašek
Josef Mašek
JTJaroslav Turanek
Jaroslav Turanek
Carbon-based nanomaterials (C-BNM) have recently attracted an increased attention as the materials with potential applications in industry and medicine. Bioresistance and proinflammatory potential of C-BNM is the main obstacle for their medicinal application which was documented in vivo and in vitro. However, there are still limited data especially on graphene derivatives such as graphene platelets (GP). In this work, we compared multi-walled carbon nanotubes (MWCNT) and two different types of pristine GP in their potential to activate inflammasome NLRP3 (The nod-like receptor family pyrin domain containing 3) in vitro. Our study is focused on exposure of THP-1/THP1-null cells and peripheral blood monocytes to C-BNM as representative models of canonical and alternative pathways, respectively. Although all nanomaterials were extensively accumulated in the cytoplasm, increasing doses of all C-BNM did not lead to cell death. We observed direct activation of NLRP3 via destabilization of lysosomes and release of cathepsin B into cytoplasm only in the case of MWCNTs. Direct activation of NLRP3 by both GP was statistically insignificant but could be induced by synergic action with muramyl dipeptide (MDP), as a representative molecule of the family of pathogen-associated molecular patterns (PAMPs). This study demonstrates a possible proinflammatory potential of GP and MWCNT acting through NLRP3 activation.

2 December 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
HPHana Petroková
Hana Petroková
JMJosef Mašek
Josef Mašek
MKMilan Kuchař
Milan Kuchař
AWAndrea Viteckova Wunschova
Andrea Viteckova Wunschova
JŠJana Štikarová
Jana Štikarová
JTJaroslav Turanek
Jaroslav Turanek
Development of tools for direct thrombus imaging represents a key step for diagnosis and treatment of stroke. Nanoliposomal carriers of contrast agents and thrombolytics can be functionalized to target blood thrombi by small protein binders with selectivity for fibrin domains uniquely formed on insoluble fibrin. We employed a highly complex combinatorial library derived from scaffold of 46 amino acid albumin-binding domain (ABD) of streptococcal protein G, and ribosome display, to identify variants recognizing fibrin cloth in human thrombus. We constructed a recombinant target as a stretch of three identical fibrin fragments of 16 amino acid peptide of the Bβ chain fused to TolA protein. Ribosome display selection followed by large-scale Enzyme-Linked ImmunoSorbent Assay (ELISA) screening provided four protein variants preferentially binding to insoluble form of human fibrin. The most specific binder variant D7 was further modified by C-terminal FLAG/His-Tag or double His-tag for the attachment onto the surface of nanoliposomes via metallochelating bond. D7-His-nanoliposomes were tested using in vitro flow model of coronary artery and their binding to fibrin fibers was demonstrated by confocal and electron microscopy. Thus, we present here the concept of fibrin-targeted binders as a platform for functionalization of nanoliposomes in the development of advanced imaging tools and future theranostics.

1 October 2017 in Toxicology Letters
Verified
Journal Article
Closed access
SMSoňa Marvanová
Soňa Marvanová
PKPavel Kulich
Pavel Kulich
RSRadim Skoupý
Radim Skoupý
FHFrantišek Hubatka
František Hubatka
MCMiroslav Ciganek
Miroslav Ciganek
MMMiroslav Machala
Miroslav Machala